Cargando…
The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years
Bone is an endocrine organ involved in modulating glucose homeostasis. The role of the bone formation marker osteocalcin (OCN) in predicting diabetes was reported, but with conflicting results. No study has explored the association between baseline bone resorption activity and incident diabetes or p...
Autores principales: | Liu, Ting-ting, Liu, Dong-mei, Xuan, Yan, Zhao, Lin, Sun, Li-hao, Zhao, Dian-dian, Wang, Xiao-feng, He, Yang, Guo, Xing-Zhi, Du, Rui, Wang, Ji-qiu, Liu, Jian-min, Zhao, Hong-yan, Tao, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496471/ https://www.ncbi.nlm.nih.gov/pubmed/28698818 http://dx.doi.org/10.1038/boneres.2017.20 |
Ejemplares similares
-
Dysglycemia and arrhythmias
por: Sun, Dong-Kun, et al.
Publicado: (2023) -
Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
por: Livadas, Sarantis, et al.
Publicado: (2022) -
Interleukin-6 May Not Affect Bone Resorption Marker CTX or Bone Formation Marker P1NP in Humans
por: Lehrskov, Louise L, et al.
Publicado: (2020) -
A Pilot Study Showing Acute Inhibitory Effect of GLP‐1 on the Bone Resorption Marker CTX in Humans
por: Nissen, Anne, et al.
Publicado: (2019) -
Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)